These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 32996305)

  • 21. Elucidation of Epigenetic Landscape in Coronary Artery Disease: A Review on Basic Concept to Personalized Medicine.
    Sumi MP; Mahajan B; Sattar RSA; Nimisha ; Apurva ; Kumar A; Sharma AK; Ahmad E; Ali A; Saluja SS
    Epigenet Insights; 2021; 14():2516865720988567. PubMed ID: 33598635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic-related therapeutic challenges in cardiovascular disease.
    Schiano C; Vietri MT; Grimaldi V; Picascia A; De Pascale MR; Napoli C
    Trends Pharmacol Sci; 2015 Apr; 36(4):226-35. PubMed ID: 25758254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetic Modifications in Cardiovascular Aging and Diseases.
    Zhang W; Song M; Qu J; Liu GH
    Circ Res; 2018 Sep; 123(7):773-786. PubMed ID: 30355081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetics, microRNA and Metabolic Syndrome: A Comprehensive Review.
    Ramzan F; Vickers MH; Mithen RF
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34068765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The quest for an effective and safe personalized cell therapy using epigenetic tools.
    Brevini TA; Pennarossa G; Manzoni EF; Gandolfi CE; Zenobi A; Gandolfi F
    Clin Epigenetics; 2016; 8():119. PubMed ID: 27891192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The emerging role of epigenetic modifiers linking cellular metabolism and gene activity in cardiac progenitor cells.
    Boonsanay V; Kim J; Braun T; Zhou Y
    Trends Cardiovasc Med; 2012 Apr; 22(3):77-81. PubMed ID: 22841836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of epigenetics in the management of cardiovascular disease: a review.
    Cao Y; Lu L; Liu M; Li XC; Sun RR; Zheng Y; Zhang PY
    Eur Rev Med Pharmacol Sci; 2014 Oct; 18(20):3097-104. PubMed ID: 25392111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interplay between different epigenetic modifications and mechanisms.
    Murr R
    Adv Genet; 2010; 70():101-41. PubMed ID: 20920747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histone code and long non-coding RNAs (lncRNAs) aberrations in lung cancer: implications in the therapy response.
    Herrera-Solorio AM; Armas-López L; Arrieta O; Zúñiga J; Piña-Sánchez P; Ávila-Moreno F
    Clin Epigenetics; 2017; 9():98. PubMed ID: 28904641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential epigenetic factors in the prediction of cardiovascular risk in diabetic patients.
    Napoli C; Benincasa G; Schiano C; Salvatore M
    Eur Heart J Cardiovasc Pharmacother; 2020 Jul; 6(4):239-247. PubMed ID: 31665258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA methylation processes in atheosclerotic plaque.
    Aavik E; Babu M; Ylä-Herttuala S
    Atherosclerosis; 2019 Feb; 281():168-179. PubMed ID: 30591183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nutritive vitamins as epidrugs.
    Nur SM; Rath S; Ahmad V; Ahmad A; Ateeq B; Khan MI
    Crit Rev Food Sci Nutr; 2021; 61(1):1-13. PubMed ID: 32023132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer epigenome.
    Lechner M; Boshoff C; Beck S
    Adv Genet; 2010; 70():247-76. PubMed ID: 20920751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic alterations as a universal feature of cancer hallmarks and a promising target for personalized treatments.
    Schnekenburger M; Florean C; Dicato M; Diederich M
    Curr Top Med Chem; 2016; 16(7):745-76. PubMed ID: 26303418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of cardiovascular pathology with epigenetically active agents: Focus on natural and synthetic inhibitors of DNA methylation and histone deacetylation.
    Chistiakov DA; Orekhov AN; Bobryshev YV
    Int J Cardiol; 2017 Jan; 227():66-82. PubMed ID: 27852009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetic Modifications in Essential Hypertension.
    Wise IA; Charchar FJ
    Int J Mol Sci; 2016 Mar; 17(4):451. PubMed ID: 27023534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aberrant Epigenetic Regulation in the Pathogenesis of Systemic Lupus Erythematosus and Its Implication in Precision Medicine.
    Zhan Y; Guo Y; Lu Q
    Cytogenet Genome Res; 2016; 149(3):141-155. PubMed ID: 27607472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigenetic modifications in colorectal cancer: molecular insights and therapeutic challenges.
    Vaiopoulos AG; Athanasoula KCh; Papavassiliou AG
    Biochim Biophys Acta; 2014 Jul; 1842(7):971-80. PubMed ID: 24561654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac epigenetics: Driving signals to the cardiac epigenome in development and disease.
    Robinson EL; Anene-Nzelu CG; Rosa-Garrido M; Foo RSY
    J Mol Cell Cardiol; 2021 Feb; 151():88. PubMed ID: 33232681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic effects of physical activity in elderly patients with cardiovascular disease.
    Recchioni R; Marcheselli F; Antonicelli R; Mensà E; Lazzarini R; Procopio AD; Olivieri F
    Exp Gerontol; 2017 Dec; 100():17-27. PubMed ID: 29074290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.